Table 1 Demographic characteristics of TMD patients who presented before and during the COVID-19 pandemic
Variables | All patients | Before COVID | During COVID | P-value |
|---|---|---|---|---|
Number of TMD patients | Â | Â | Â | Â |
n (%) | 838 (100) | 367 (100) | 471 (100) | Â |
Sex | Â | Â | Â | Â |
Female, n (%) | 626 (74.7) | 276 (75.2) | 350 (74.3) | 0.768 |
Male, n (%) | 212 (25.3) | 91 (24.8) | 121 (25.7) | |
Female;male ratio | 3.0 | 3.0 | 2.9 | Â |
Age | Â | Â | Â | Â |
Mean (SD) | 32.10 (15.52) | 30.86 (14.77) | 33.07 (16.02) | 0.082^ |
Median (IQR) | 27.00 (18.00) | 27.00 (15.00) | 28.00 (19.00) | |
Age groups, n (%) | Â | Â | Â | Â |
Adolescents/young adults | 673 (80.3) | 304 (82.8) | 369 (78.3) | 0.105 |
Middle-aged/older adults | 165 (19.7) | 63 (17.2) | 102 (21.7) | |
TMD duration (months) | Â | Â | Â | Â |
Mean (SD) | 16.80 (37.12) | 17.48 (39.89) | 16.27 (34.85) | 0.520^ |
Median (IQR) | 3.00 (11.50) | 3.00 (11.50) | 3.00 (11.33) | Â |